Klaudyne Hong, Founder - AI Improving Clinical Outcomes

Join Sal Daher's Investment Syndicate: Click to Subscribe The sense of purpose and focus that led Klaudyne Hong to do her PhD at MIT in two years helped her turn a chance comment during a fly-fishing trip into a groundbreaking startup. Peach IntelliHealth is building AI for acute medical care. Her project was seeded by the Government of Singapore where she found great help in building her data set. She's now seeking FDA approval. Highlights include: Sal Daher Introduces Klaudyne Hong, PhD, Founder of Peach Intellihealth What Peach Intellihealth Does Peach Intellihealth's AI Can Predict a Patient's Response to Treatment The Founding Story of Peach Intellihealth "So, if you don't remember anything about what I say today, remember the next point. It's the highlight of the show, okay? I actually caught two striped bass that morning." "And we started then doing a historical analysis, and we realized that our algorithms actually fit that data very nicely." Peach's AI Got Regulatory Approval in Singapore – Now Replicating Pivotal Study in the U.S. "Sepsis, by the way, is the most expensive health care condition, hospitalized condition, in the U.S." "If someone's going to go into cardiac arrest, and you know it several hours in advance, you can make a huge difference." Current Status of Peach Intellihealth Funding for Peach Intellihealth – the Government of Singapore Came in as a Seed Investor "I grew up in Singapore, and I left when I was relatively young. So, I was as an undergrad in California." Her Favorite Show "Cheers" Showed Boston in Such a Good Light that Klaudyne Chose to Apply to MIT "…my thesis…was about controlling gene expression for gene therapy applications." Klaudyne's Two-Year PhD "I drew him a picture of this DNA that was wearing cowboy boots, and somehow told him it's all about the cowboy boot being a gene therapy vector. And somehow, he understood what I was saying. He said, "Yeah, come join me in the lab."" Klaudyne Hong's Entrepreneurial Journey After J&J Klaudyne Consulted but Found It Unrewarding, Lacking Ownership – Enter Entrepreneurship Peach Benefitted from the Entrepreneurial Ecosystem in Singapore that Allowed the Rapid Acquisition of Patient Data "But I find that the larger the company, sometimes the slower things can be, because I think they call way too many meetings that you have to attend." "They see that you have this passion. And they see that look, if it's that crazy, why do you have so many good people embarking on this journey with you?" "It is the most robustly supported result in the study of entrepreneurship that more co-founders, better chance of success." Where the AI Will Fit in the Clinic "I also see AI in a sense of helping make informed choices about the kinds of medicine we take." Sal Talks About Portfolio Company Leuko Klaudyne Hong's Closing Comments